{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T20:07:21Z","timestamp":1785614841448,"version":"3.56.0"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100023092","name":"Old Dominion University - College of Sciences","doi-asserted-by":"publisher","award":["IRP2021-22"],"award-info":[{"award-number":["IRP2021-22"]}],"id":[{"id":"10.13039\/100023092","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Long-acting injectable pre-exposure prophylaxis (LAI-PrEP) for HIV prevention may improve adherence for those with concerns with daily pills. Limited data exist on LAI-PrEP acceptability among Black women in the U.S., a population vulnerable to HIV. We assessed willingness to use LAI-PrEP among Black women eligible for PrEP in the Southern U.S.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We conducted a cross-sectional online survey of HIV-negative Black women from March to June 2022 in the U.S. South. Participants provided information on sociodemographic characteristics, HIV knowledge, PrEP awareness, and use, stigma, risk perception, medical mistrust, and healthcare access. Multivariate logistic regression models determined factors associated with willingness to use LAI-PrEP.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Of 491 women, the mean (SD) age was 40.1 (17.5), 53% of participants had a college degree or lower, 79% were single, and 80% resided in urban\/suburban settings. Thirty-nine percent were aware of PrEP before the study and 36.7% of women were willing to use LAI-PrEP. In multivariate analyses, PrEP awareness [adjusted odds ratio (aOR=2.37, 95% CI 1.40, 3.73, p\u2009&lt;\u20090.001), having a personal clinician (aOR=2.01, 95% CI 1.10, 3.68, p\u2009=\u20090.02), HIV worried (aOR=1.78, 95% CI 1.09, 2.89, p\u2009=\u20090.02), and medical trust (aOR=1.41, 95% CI 1.03, 1.93, p\u2009=\u20090.04) were statistically associated with willingness to use LAI-PrEP. However, the healthcare stereotype (beliefs that healthcare is biased) had lower odds of using LAI-PrEP (aOR=0.94, 95% CI 0.89, 0.99, p\u2009=\u20090.04).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Black women at risk for HIV are more likely to consider injectable PrEP when they understand HIV risk factors, are aware of PrEP, have a clinician, and trust the medical care. Implementing client-centered care interventions could effectively address medical mistrust and enhance engagement in HIV prevention services among Black women.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0330698","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T17:22:41Z","timestamp":1756833761000},"page":"e0330698","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among black cisgender women in the Southern United States"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8095-233X","authenticated-orcid":true,"given":"Sylvia","family":"Shangani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3075-8061","authenticated-orcid":true,"given":"Jaquetta M.","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Heron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Sales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K.","family":"Mugwanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"pone.0330698.ref001","volume-title":"Lifetime Risk of HIV Diagnosis","author":"Center for Disease Control and Prevention","year":"2016"},{"key":"pone.0330698.ref002","unstructured":"Center for Disease Control and Prevention. New HIV Surveillance Report 2024. https:\/\/www.cdc.gov\/nchhstp\/director-letters\/cdc-publishes-new-hiv-surveillance-reports.html"},{"key":"pone.0330698.ref003","author":"Center for Disease Control and Prevention","year":"2024"},{"issue":"9","key":"pone.0330698.ref004","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2019.1343","article-title":"Ending the HIV Epidemic: A Plan for the United States","volume":"321","author":"AS Fauci","year":"2019","journal-title":"Jama"},{"key":"pone.0330698.ref005","volume-title":"National HIV\/AIDS Strategy for the United States 2022-2025","author":"White House","year":"2022"},{"issue":"5","key":"pone.0330698.ref006","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"JM Baeten","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0330698.ref007","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana","volume":"367","author":"MC Thigpen","year":"2012","journal-title":"N Engl J Med"},{"issue":"10013","key":"pone.0330698.ref008","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"S McCormack","year":"2016","journal-title":"Lancet"},{"key":"pone.0330698.ref009","unstructured":"U.S. Food & Drug Administration. FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention. 2021. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention"},{"issue":"8","key":"pone.0330698.ref010","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jama.2023.14461","article-title":"Preexposure Prophylaxis to Prevent Acquisition of HIV: US Preventive Services Task Force Recommendation Statement","volume":"330","author":"US Preventive Services Task Force","year":"2023","journal-title":"JAMA"},{"issue":"2","key":"pone.0330698.ref011","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/1556264618755919","article-title":"\u201cWhere Did This [PrEP] Come From?\u201d African American Mother\/Daughter Perceptions Related to Adolescent Preexposure Prophylaxis (PrEP) Utilization and Clinical Trial Participation","volume":"13","author":"FE Fletcher","year":"2018","journal-title":"J Empir Res Hum Res Ethics"},{"issue":"1","key":"pone.0330698.ref012","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/QAI.0000000000001762","article-title":"HIV Pre-Exposure Prophylaxis Stigma as a Multidimensional Barrier to Uptake Among Women Who Attend Planned Parenthood","volume":"79","author":"SK Calabrese","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"pone.0330698.ref013","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jana.2018.03.005","article-title":"PrEParing Women to Prevent HIV: An Integrated Theoretical Framework to PrEP Black Women in the United States","volume":"29","author":"C Chapman Lambert","year":"2018","journal-title":"J Assoc Nurses AIDS Care"},{"issue":"2","key":"pone.0330698.ref014","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s15010-015-0850-2","article-title":"HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans","volume":"44","author":"CD Spinner","year":"2016","journal-title":"Infection"},{"issue":"6","key":"pone.0330698.ref015","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1177\/1557988318797437","article-title":"Stigma and Shame Experiences by MSM Who Take PrEP for HIV Prevention: A Qualitative Study","volume":"12","author":"A Dubov","year":"2018","journal-title":"Am J Mens Health"},{"issue":"6","key":"pone.0330698.ref016","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s10461-020-03107-6","article-title":"Addressing Unhealthy Alcohol Use and the HIV Pre-exposure Prophylaxis Care Continuum in Primary Care: A Scoping Review","volume":"25","author":"BJ Oldfield","year":"2021","journal-title":"AIDS Behav"},{"issue":"10337","key":"pone.0330698.ref017","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(22)00538-4","article-title":"Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial","volume":"399","author":"S Delany-Moretlwe","year":"2022","journal-title":"Lancet"},{"issue":"5","key":"pone.0330698.ref018","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/hiv.13439","article-title":"Pregnancy outcomes and pharmacokinetics in pregnant women living with HIV exposed to long-acting cabotegravir and rilpivirine in clinical trials","volume":"24","author":"P Patel","year":"2023","journal-title":"HIV Med"},{"issue":"10","key":"pone.0330698.ref019","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1007\/s10461-020-02843-z","article-title":"HIV-Related Mistrust (or HIV Conspiracy Theories) and Willingness to Use PrEP Among Black Women in the United States","volume":"24","author":"BO Ojikutu","year":"2020","journal-title":"AIDS Behav"},{"issue":"5","key":"pone.0330698.ref020","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/cid\/ciz046","article-title":"US Guideline Criteria for Human Immunodeficiency Virus Preexposure Prophylaxis: Clinical Considerations and Caveats","volume":"69","author":"SK Calabrese","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"22","key":"pone.0330698.ref021","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1001\/jama.2019.6390","article-title":"Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement","volume":"321","author":"Force US Preventive Services Task","year":"2019","journal-title":"JAMA"},{"issue":"6","key":"pone.0330698.ref022","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/1524839912470453","article-title":"Psychometric properties of an HIV knowledge scale administered with populations at high risk for HIV infection","volume":"14","author":"WH Oglesby","year":"2013","journal-title":"Health Promot Pract"},{"key":"pone.0330698.ref023","unstructured":"National Institute on Alcohol Abuse and Alcoholism. What is binge drinking? 2021. https:\/\/www.niaaa.nih.gov\/publications\/brochures-and-fact-sheets\/binge-drinking"},{"issue":"2","key":"pone.0330698.ref024","first-page":"185","article-title":"The Pre-Exposure Prophylaxis (PrEP) Stigma Scale: Preliminary findings from a pilot study","volume":"11","author":"H Klein","year":"2019","journal-title":"Int Public Health J"},{"issue":"2","key":"pone.0330698.ref025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ypmed.2003.09.041","article-title":"The Group-Based Medical Mistrust Scale: psychometric properties and association with breast cancer screening","volume":"38","author":"HS Thompson","year":"2004","journal-title":"Prev Med"},{"issue":"3","key":"pone.0330698.ref026","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1037\/a0036946","article-title":"Stereotype threat among black and white women in health care settings","volume":"20","author":"CM Abdou","year":"2014","journal-title":"Cultur Divers Ethnic Minor Psychol"},{"issue":"5","key":"pone.0330698.ref027","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s12325-020-01295-0","article-title":"Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review","volume":"37","author":"KH Mayer","year":"2020","journal-title":"Adv Ther"},{"issue":"4","key":"pone.0330698.ref028","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s10461-017-1972-6","article-title":"MSM at Highest Risk for HIV Acquisition Express Greatest Interest and Preference for Injectable Antiretroviral PrEP Compared to Daily, Oral Medication","volume":"22","author":"KB Biello","year":"2018","journal-title":"AIDS Behav"},{"issue":"3","key":"pone.0330698.ref029","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10461-020-03023-9","article-title":"Interest in Long-Acting Injectable Pre-exposure Prophylaxis (LAI PrEP) Among Women in the Women\u2019s Interagency HIV Study (WIHS): A Qualitative Study Across Six Cities in the United States","volume":"25","author":"MM Philbin","year":"2021","journal-title":"AIDS Behav"},{"issue":"4","key":"pone.0330698.ref030","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1007\/s10461-017-1851-1","article-title":"Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users","volume":"22","author":"R Shrestha","year":"2018","journal-title":"AIDS Behav"},{"issue":"7","key":"pone.0330698.ref031","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2101016","article-title":"Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women","volume":"385","author":"RJ Landovitz","year":"2021","journal-title":"N Engl J Med"},{"issue":"10279","key":"pone.0330698.ref032","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0140-6736(21)00395-0","article-title":"Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses","volume":"397","author":"PS Sullivan","year":"2021","journal-title":"Lancet"},{"key":"pone.0330698.ref033","unstructured":"Kaiser Family Foundation. Status of state Medicaid expansion decisions: Interactive map. 2024. https:\/\/www.kff.org\/affordable-care-act\/issue-brief\/status-of-state-medicaid-expansion-decisions-interactive-map\/"},{"issue":"3","key":"pone.0330698.ref034","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/QAI.0000000000001497","article-title":"Challenges in Translating PrEP Interest Into Uptake in an Observational Study of Young Black MSM","volume":"76","author":"C-P Rolle","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"pone.0330698.ref035","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1080\/09540121.2019.1612023","article-title":"Awareness and Acceptability of pre-exposure prophylaxis (PrEP) among gay, bisexual and other men who have sex with men (GBMSM) in Kenya","volume":"31","author":"A Ogunbajo","year":"2019","journal-title":"AIDS Care"},{"issue":"9","key":"pone.0330698.ref036","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1089\/jwh.2018.7353","article-title":"Factors Affecting Pre-Exposure Prophylaxis Implementation for Women in the United States: A Systematic Review","volume":"28","author":"E Bradley","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"issue":"2","key":"pone.0330698.ref037","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/08964289.2019.1619511","article-title":"Towards a More Inclusive and Dynamic Understanding of Medical Mistrust Informed by Science","volume":"45","author":"J Jaiswal","year":"2019","journal-title":"Behav Med"},{"issue":"2","key":"pone.0330698.ref038","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/08964289.2019.1585324","article-title":"HIV-Related Medical Mistrust, HIV Testing, and HIV Risk in the National Survey on HIV in the Black Community","volume":"45","author":"LM Bogart","year":"2019","journal-title":"Behav Med"},{"issue":"7","key":"pone.0330698.ref039","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s10461-018-2283-2","article-title":"Differences in Medical Mistrust Between Black and White Women: Implications for Patient-Provider Communication About PrEP","volume":"23","author":"M Tekeste","year":"2019","journal-title":"AIDS Behav"},{"issue":"11","key":"pone.0330698.ref040","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1080\/09540121.2017.1300633","article-title":"Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts","volume":"29","author":"S Cahill","year":"2017","journal-title":"AIDS Care"},{"issue":"6","key":"pone.0330698.ref041","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1007\/s10461-016-1657-6","article-title":"The Health and Sociocultural Correlates of AIDS Genocidal Beliefs and Medical Mistrust Among African American MSM","volume":"22","author":"KG Quinn","year":"2018","journal-title":"AIDS Behav"},{"issue":"2","key":"pone.0330698.ref042","doi-asserted-by":"crossref","DOI":"10.2105\/AJPH.2014.302322","article-title":"The role of stigma and medical mistrust in the routine health care engagement of black men who have sex with men","volume":"105","author":"LA Eaton","year":"2015","journal-title":"Am J Public Health"},{"issue":"10","key":"pone.0330698.ref043","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1080\/09540121.2014.894617","article-title":"Perceptions of barriers and facilitators to cervical cancer screening among low-income, HIV-infected women from an integrated HIV clinic","volume":"26","author":"FE Fletcher","year":"2014","journal-title":"AIDS Care"},{"issue":"1","key":"pone.0330698.ref044","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1186\/s12889-016-3364-7","article-title":"Socioecological factors influencing women\u2019s HIV risk in the United States: qualitative findings from the women\u2019s HIV SeroIncidence study (HPTN 064)","volume":"16","author":"PM Frew","year":"2016","journal-title":"BMC Public Health"},{"issue":"11","key":"pone.0330698.ref045","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1007\/s10461-018-2067-8","article-title":"Facilitators and Barriers to Pre-Exposure Prophylaxis (PrEP) Use Among Black Individuals in the United States: Results from the National Survey on HIV in the Black Community (NSHBC)","volume":"22","author":"BO Ojikutu","year":"2018","journal-title":"AIDS Behav"},{"issue":"1","key":"pone.0330698.ref046","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/13557858.2020.1841120","article-title":"The impact of COVID-19 among Black women: evaluating perspectives and sources of information","volume":"26","author":"R Chandler","year":"2021","journal-title":"Ethn Health"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0330698","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T17:22:46Z","timestamp":1756833766000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0330698"}},"subtitle":[],"editor":[{"given":"Swarnali","family":"Goswami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":46,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0330698","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]}}}